EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage

Max Ak Rätze, Lotte Nfl Enserink, Noboru Ishiyama, Sven van Kempen, Christina Hj Veltman, Isaac J Nijman, Wisse E Haakma, Carlos Caldas, René Bernards iD, Paul J van Diest iD, Matthias Christgen iD, Thijs Koorman iD und 1 weitere

The Journal of Pathology · 2025

DOI: 10.1002/path.6394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2025. Verfasst von Max Ak Rätze und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Cadherins, Breast Neoplasms, Actins, Microfilament Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Cooperation in Science and Technology, Horizon 2020 Framework Programme, KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Afadin is a multimodal scaffolding protein with essential functions in cell–cell adhesion. Although its loss of expression has been linked to breast cancer invasion and metastasis, the underlying mechanisms driving tumour progression upon mutational Afadin ( AFDN ) loss in breast cancers remains unclear. In the current study we identified a somatic frameshift AFDN mutation ( p .Lys630fs) in an invasive breast cancer sample that coincides with loss of Afadin protein expression. Functional studies in E‐cadherin‐expressing breast cancer cells show that Afadin loss leads to immature and aberrant adherens junction (AJ) formation. The lack of AJ maturation results in a noncohesive cellular phenotype accompanied by Actomyosin‐dependent anoikis resistance, which are classical progression hallmarks of single‐cell breast cancer invasion. Reconstitution experiments using Afadin truncates show that proper F‐actin organisation and epithelial cell–cell adhesion critically depend on the Coiled‐Coil domain of Afadin but not on the designated C‐terminal F‐actin binding domain. Mouse xenograft experiments based on cell lines and primary patient‐derived breast cancer organoids demonstrate that Afadin loss induces single‐cell lobular‐type invasion phenotypes and overt dissemination to the lungs and the peritoneum. In short, Afadin is a metastasis suppressor for breast cancer through stabilisation and maturation of a mechanical E‐cadherin to F‐actin outside‐in link. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsBreast NeoplasmsActinsMicrofilament ProteinsAntigens, CDHumansFemaleAnimalsAdherens JunctionsCell AdhesionMiceCell Line, TumorNeoplasm InvasivenessNeoplasm MetastasisAnoikisMutation

Stichwörter der Autor:innen

AfadinE‐cadherinadherens junctionmetastatic breast cancer

Substanzen

CadherinsafadinActinsMicrofilament ProteinsCDH1 protein, humanAntigens, CD

Autor:innen und Institutionen

  • Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Launchpad Therapeutics, Inc, Cambridge, MA, USA.
  • Center for Molecular Medicine, Cancer Genomics Netherlands, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Department of Oncology, University of Cambridge, Cambridge, UK.
  • Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

ORCID-Profile: René Bernards, Paul J van Diest, Matthias Christgen, Thijs Koorman, Patrick Wb Derksen

Förderung

  • European Cooperation in Science and Technology
  • Horizon 2020 Framework Programme
  • KWF Kankerbestrijding
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Breast Cancer Now

Zitieren

APA

Rätze, M. A., Enserink, L. N., Ishiyama, N., van Kempen, S., Veltman, C. H., Nijman, I. J., Haakma, W. E., Caldas, C., Bernards, R., van Diest, P. J., Christgen, M., Koorman, T., & Derksen, P. W. (2025). Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage. The Journal of Pathology. https://doi.org/10.1002/path.6394

Vancouver

Rätze MA, Enserink LN, Ishiyama N, van Kempen S, Veltman CH, Nijman IJ, et al. Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage. The Journal of Pathology. 2025. doi:10.1002/path.6394

BibTeX
@article{Rtze2025,
  author = {Rätze, Max Ak and Enserink, Lotte Nfl and Ishiyama, Noboru and van Kempen, Sven and Veltman, Christina Hj and Nijman, Isaac J and Haakma, Wisse E and Caldas, Carlos and Bernards, René and van Diest, Paul J and Christgen, Matthias and Koorman, Thijs and Derksen, Patrick Wb},
  title = {Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6394}
}
Kostenlos starten →